home.social

#europeancommissionapproval — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #europeancommissionapproval, aggregated by home.social.

fetched live
  1. Lilly’s Foundayo Pill Gets European Regulatory Backing – LLY Stock Heads For Best Week In Nearly Four Months

    European Medicines Agency’s advisory committee recommended approval of its once-daily weight-loss pil…
    #Europe #EU #EliLilly #EliLillyObesityDrug #EMACHMPRecommendation #European #EuropeanCommissionapproval #foundayo #FoundayoEUApproval #FoundayoQ2Sales #FoundayoWeightLossPill #GLP-1WeightLossDrugs #llystock #OralWeightLossTreatment #Orforglipron
    europesays.com/europe/160726/

  2. European Commission grants marketing authorisation for NEZGLYAL, first pharmacological treatment for cALD

    European Commission grants marketing authorisation for NEZGLYAL, first pharmacological treatment for cALD September 28, 2026 | M…
    #Europe #EU #(cALD) #(leriglitazone) #cerebraladrenoleukodystrophy #CNS #EuropeanCommissionapproval #EuropeanUnion #MinoryxTherapeutics #Neuraxpharm #NEXUStrial #NEZGLYAL® #OrphanDrug #PPARgammaagonist #raredisease #X-ALD
    europesays.com/europe/147909/

  3. BioNTech wins EU nod for XFG COVID-19 vaccine | BNTX SEC Filing

    Washington, D.C. 20549 Indicate by check mark whether the registrant files or will file annual reports under cover…
    #Europe #EU #EuropeanCommission #BioNTech #BNTX #COVID-19vaccine #EMA #EUauthorization #EuropeanCommissionapproval #Form6-K #marketingauthorization #Pfizer #XFGvariant
    europesays.com/europe/105356/

  4. AbbVie Gets EU Approval for RINVOQ in Vitiligo

    RINVOQ is the first and only systemic medication approved in the European Union to treat adult and adolescent…
    #Europe #EU #EuropeanCommission #ABBV #AbbVie #EuropeanCommissionapproval #non-segmentalvitiligo #Phase3Viti-Up #repigmentation #RINVOQ #upadacitinib
    europesays.com/europe/104745/

  5. AbbVie wins EU approval for SKYRIZI in children

    SKYRIZI® (risankizumab) expands its indication for children and adolescents six years of age and older with moderate to…
    #Europe #EU #EuropeanCommission #ABBV #AbbVie #biopharma #EuropeanCommissionapproval #pediatricplaquepsoriasis #Phase3 #risankizumab #SKYRIZI
    europesays.com/europe/77471/

  6. EU approves Bristol Myers Squibb’s Opdivo for advanced lymphoma

    Bristol Myers Squibb (NYSE:BMY) secured a major regulatory milestone on Monday as the European Commission approved its blockbuster…
    #Europe #EU #EuropeanCommission #BMY #BristolMyersSquibb #classicalHodgkinLymphoma #EuropeanCommissionapproval #frontlinecancertreatment #Immunotherapy #nivolumab #oncologynews #Opdivo #SWOG1826
    europesays.com/europe/57461/

  7. Crinetics wins EU approval for acromegaly drug Palsonify





    Crinetics Pharmaceuticals (NASDAQ: CRNX) announced European Commission approval of PALSONIFY (paltusotine) for treatment…
    #Europe #EU #EuropeanCommission #acromegaly #CrineticsPharmaceuticals #CRNX #drugapproval #EuropeanCommissionapproval #Palsonify #paltusotine #raredisease
    europesays.com/europe/24538/

Share on Mastodon

Enter the server where you have an account.